We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+5.7%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$7.68B
AUM Growth
+$101M
Cap. Flow
-$193M
Cap. Flow %
-2.51%
Top 10 Hldgs %
17.01%
Holding
1,082
New
298
Increased
225
Reduced
230
Closed
304

Top Sells

Rank Stock Value
1
TMUS icon
T-Mobile US
TMUS
+$97.3M
2
AGN
Allergan Inc
AGN
+$79.1M
3
MU icon
Micron Technology
MU
+$67M
4
HPQ icon
HP
HPQ
+$65.4M
5
BAX icon
Baxter International
BAX
+$55.7M

Sector Composition

Rank Sector Weight
1 Healthcare 21.38%
2 Financials 13.7%
3 Communication Services 11.26%
4 Technology 9.89%
5 Industrials 8.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZTS icon
1
Zoetis
ZTS
$31.7B
$201M 2.62%
4,349,880
+488,791
+13% +$22M
AGN
2
DELISTED
Allergan plc
AGN
$187M 2.44%
628,297
+429,765
+216% +$123M
TMUS icon
3
T-Mobile US
TMUS
$193B
$174M 2.26%
5,477,916
-3,119,851
-36% -$97.3M
EPI icon
4
WisdomTree India Earnings Fund ETF
EPI
$2.02B
$128M 1.66%
5,599,188
AZO icon
5
AutoZone
AZO
$47.7B
$124M 1.61%
181,644
-43,979
-19% -$27.6M
PFE icon
6
Pfizer
PFE
$140B
$121M 1.57%
3,660,426
+707,173
+24% +$22.5M
CMCSA icon
7
Comcast
CMCSA
$79.7B
$101M 1.31%
3,572,790
+617,448
+21% +$17.8M
C icon
8
Citigroup
C
$222B
$92.4M 1.2%
1,794,106
+563,605
+46% +$28.7M
COF icon
9
Capital One
COF
$124B
$91.6M 1.19%
1,162,391
+169,430
+17% +$13.3M
CVS icon
10
CVS Health
CVS
$137B
$86M 1.12%
832,803
+745,671
+856% +$75.5M
LBTYK icon
11
Liberty Global Class C
LBTYK
$3.18B
$75.2M 0.98%
1,866,214
+161,154
+9% +$6.38M
AAL icon
12
American Airlines Group
AAL
$9.52B
$75.2M 0.98%
1,424,555
-215,035
-13% -$10.9M
META icon
13
Meta Platforms (Facebook)
META
$1.53T
$71.5M 0.93%
869,576
+555,703
+177% +$43.5M
COO icon
14
Cooper Companies
COO
$13.8B
$69.4M 0.9%
1,481,156
-223,996
-13% -$9.46M
VMW
15
DELISTED
VMware, Inc
VMW
$69.2M 0.9%
843,379
+760,918
+923% +$62.2M
CFG icon
16
Citizens Financial Group
CFG
$30.4B
$67.7M 0.88%
2,804,093
+890,408
+47% +$21.8M
MOS icon
17
The Mosaic Company
MOS
$7.13B
$59.3M 0.77%
1,287,629
-357,255
-22% -$17.4M
CCEP icon
18
Coca-Cola Europacific Partners
CCEP
$46.5B
$57.9M 0.75%
1,309,422
+1,173,562
+864% +$51.2M
HSY icon
19
Hershey
HSY
$35.3B
$55.6M 0.72%
550,666
+34,320
+7% +$3.58M
BMY icon
20
Bristol-Myers Squibb
BMY
$127B
$53.9M 0.7%
835,347
+804,386
+2,598% +$50.4M
GOOG icon
21
Alphabet (Google) Class C
GOOG
$3.92T
$52.4M 0.68%
1,894,868
+1,646,789
+664% +$44.1M
LAZ icon
22
Lazard
LAZ
$4.36B
$51.7M 0.67%
982,185
+200,996
+26% +$9.9M
V icon
23
Visa
V
$673B
$51.6M 0.67%
788,184
+755,816
+2,335% +$50M
VTRS icon
24
Viatris
VTRS
$20.1B
$50.2M 0.65%
+845,509
New +$48.2M
ON icon
25
ON Semiconductor
ON
$33.9B
$49.7M 0.65%
+4,103,352
New +$47M

Similar funds

Marshall Wace's Q1 2015 Portfolio in Review

As of Q1 2015, Marshall Wace held 1,082 positions worth $7.68B, up 1.3% from $7.57B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Marshall Wace's Q1 2015 filing shows 298 new, 225 increased, 230 reduced and 304 closed positions. Its largest new stake was Viatris: 845,509 shares worth $50.2M. The largest sale was T-Mobile US, an estimated $97.3M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 18% a quarter earlier, followed by Financials and Communication Services.

  • Marshall Wace's largest Q1 2015 buy was Viatris: 845,509 shares worth $50.2M.
  • Marshall Wace added most to Allergan plc in Q1 2015, an estimated $123M increase.
  • Marshall Wace's biggest Q1 2015 reduction was T-Mobile US, cutting an estimated $97.3M.
  • Marshall Wace fully exited Allergan Inc in Q1 2015, selling an estimated $79.1M.
  • Marshall Wace's ten largest holdings make up 17% of its $7.68B portfolio in Q1 2015.
  • Marshall Wace opened 298 new positions and closed 304 in Q1 2015.
  • Marshall Wace's portfolio value rose 1.3% quarter-over-quarter to $7.68B.

Based on Marshall Wace's 13F filing for Q1 2015, filed 11 May 2015.